News
Rani Therapeutics Presents Promising Data at ENDO 2025
July 14, 2025 • News
Companies mentioned:
Rani Therapeutics shares are trading higher after the company presented data at ENDO 2025 demonstrating bioequivalence of its RaniPill for oral delivery of a bispecific GLP-1/GLP-2 receptor agonist compared to subcutaneous injection.